NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Oct. 30, 2015--
Lantheus
Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus
Medical Imaging, Inc. (“LMI”), today announced that it will be
participating in the 24th Annual Credit Suisse Healthcare
Conference on Wednesday, November 11, 2015 in Scottsdale, Arizona. Mary
Anne Heino, President and Chief Executive Officer, and John Bakewell,
Chief Financial Officer, will represent the Company in a session
scheduled at 8:30 a.m. (Mountain Standard Time).
To access a live webcast of the presentation, please visit the Company’s
website at www.lantheus.com.
A replay of the webcast will be available on the Company’s website for
30 days following the live presentation.
About Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc.
Lantheus
Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc.
(“LMI”), which is a global leader in developing, manufacturing, selling
and distributing innovative diagnostic imaging agents and products. LMI
provides a broad portfolio of products, which are primarily used for the
diagnosis of cardiovascular diseases. LMI’s key products include the
echocardiography contrast agent DEFINITY® Vial for
(Perflutren Lipid Microsphere) Injectable Suspension; TechneLite®
(Technetium Tc99m Generator), a technetium-based generator that provides
the essential medical isotope used in nuclear medicine procedures; and
Xenon (Xenon Xe 133 Gas), an inhaled radiopharmaceutical imaging agent
used to evaluate pulmonary function and for imaging the lungs. The
Company is headquartered in North Billerica, Massachusetts, and has
offices in Puerto Rico, Canada and Australia. For more information,
visit www.lantheus.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151030006028/en/
Source: Lantheus Holdings, Inc.
Lantheus Holdings, Inc.
Investor
Relations
John Bakewell, 978-436-7073
or
Media
Relations
Meara Murphy, 978-671-8508
